Kimber Rothwell

Australian Listed Company focused on the development of AI products for detecting structural heart disease and heart failure.

As a report to the Board of Directors, my duties encompassed corporate strategy, financial oversight, regulatory adherence, investor relations, and the strategy and commercialization of products.

My executive team included five direct reports (CTO, CCO, CRO, CMO, CSO) and 15 full-time employees across the US and Australia.

During my tenure,

• I reoriented the company's strategic vision and narrative;
• Collaborated with the executive team to develop our 'Big Idea' for delivering and capturing more value;
• Established a Long-Range Planning (LRP) process and budget model, including annual profit and loss forecasting;
• Implemented a delegation of authority framework and established a risk management framework;
• Managed relationships with brokers, shareholders, stakeholders, customers, and other key parties;
• Provided commericial guidance related to corporate operations.

Change Healthcare operates under United Health Group, a corporation listed on the NYSE, with an annual revenue of USD $324 billion and a global workforce of 400,000 employees.

As the Markets Leader for APAC and P&L owner for ANZ in the diagnostic imaging sector, I am responsible for a USD $10 million annual budget, 15 full-time employees, and three direct reports.

My areas of oversight include Strategic Partnerships, Project Services, Support Services, Sales, and Administration.

• My achievements include:
  Consistently meeting 100% of sales and revenue targets for five consecutive years.
• Attaining 40% EBITDA annually through enhanced resource management, superior program management, and stringent cost control.
• Securing 23 new contracts with both public and private healthcare providers.
• Maintaining a 95% customer retention rate across the portfolio.
• Initiating and finalizing sales distribution agreements with GE and TeraRecon.

A Fortune 500 company, ranked #5, with an annual revenue of USD $276 billion, following the acquisition of McKesson Technology Solutions by Change Healthcare.

Directed the sales and marketing organization, overseeing an annual sales budget of USD $20M across three business units: diagnostic imaging, provider analytics, and workforce management.

• Consistently achieved 100% of the sales quota year-over-year in highly competitive clinical domains;
• Spearheaded the market evaluation and developed the business case for entering the diagnostic imaging market in Australia;
• Elevated to the position of Vice President of Sales for the Asia-Pacific region after the acquisition by Change Healthcare.

As an international distributor and reseller, we specialize in digital health products for healthcare providers.

Our strategic business development initiatives have been crafted to boost sales, expand market share, and enhance profitability.

In FY14-15, we successfully increased our annual bookings from AUD$1.5 million to AUD$3 million. We secured enterprise agreements with QLD Health, NSW Health, and Farrer Park Hospital. Additionally, we formed consortia partnerships with PwC and Deloitte.

As a Tier 1 global professional services provider, we cater to a broad range of clients, both international and domestic, including listed and private entities.

My responsibility encompasses the formulation and implementation of the firm's strategy, focusing on delivering sector-specific services to early-stage and middle-market companies, particularly in the Technology and Media, Retail and Consumer, and Industrial sectors.

We successfully increased the portfolio's annual revenue from AUD$230 million to AUD$264 million between FY09-11, managing 200 clients.